A phase 2, randomized, double-blind, placebo-controlled study of ubenimex in patients with pulmonary arterial hypertension (WHO Group 1) (LIBERTY)
Administered By
Awarded By
Contributors
- Rajagopal, Sudarshan Principal Investigator
Start/End
- June 1, 2016 - December 31, 2018